Pulike Biological Engineering, Inc. (SHA:603566)
China
· Delayed Price · Currency is CNY 12.01
-0.44 (-3.53%)
Apr 29, 2026, 3:00 PM CST
SHA:603566 Revenue
In the year 2025, Pulike Biological Engineering had annual revenue of 1.09B CNY with 4.54% growth. Pulike Biological Engineering had revenue of 266.87M in the quarter ending December 31, 2025, a decrease of -4.97%.
Revenue
1.09B
Revenue Growth
+4.54%
P/S Ratio
3.77
Revenue / Employee
702.69K
Employees
1,551
Market Cap
4.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.09B | 47.32M | 4.54% |
| Dec 31, 2024 | 1.04B | -210.13M | -16.77% |
| Dec 31, 2023 | 1.25B | 22.62M | 1.84% |
| Dec 31, 2022 | 1.23B | 131.50M | 11.97% |
| Dec 31, 2021 | 1.10B | 170.06M | 18.31% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Obio Technology (Group) Corp. | 267.70M |
| Hefei Lifeon Pharmaceutical | 1.55B |
| Boji Medical Technology | 949.94M |
| Beijing Bohui Innovation Biotechnology Group | 824.58M |
| Hinova Pharmaceuticals | 46.50M |
| Baolingbao Biology | 2.81B |
| Assure Tech (Hangzhou) | 453.58M |
| Guanhao Biotech | 387.75M |